Gumimba, Earl Ian B.

HRN: 23-64-97  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/03/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/03/2023
09/09/2023
IV
4.5g
Q6
Sepsis Secondary To Infected Sacral Ulcer
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: